ATE244581T1 - Fibrindichtungsmittelzusammensetzungen und verfahren zu deren verwendung - Google Patents

Fibrindichtungsmittelzusammensetzungen und verfahren zu deren verwendung

Info

Publication number
ATE244581T1
ATE244581T1 AT93308029T AT93308029T ATE244581T1 AT E244581 T1 ATE244581 T1 AT E244581T1 AT 93308029 T AT93308029 T AT 93308029T AT 93308029 T AT93308029 T AT 93308029T AT E244581 T1 ATE244581 T1 AT E244581T1
Authority
AT
Austria
Prior art keywords
fibrine
methods
sealant compositions
fibrin
sealant
Prior art date
Application number
AT93308029T
Other languages
English (en)
Inventor
Peter Andrew David Edwardson
John Esam Fairbrother
Ronald Stephen Gardner
Derek Andrew Hollingsbee
Stuart Anth Cederholm-Williams
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of ATE244581T1 publication Critical patent/ATE244581T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93308029T 1992-10-08 1993-10-08 Fibrindichtungsmittelzusammensetzungen und verfahren zu deren verwendung ATE244581T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95821292A 1992-10-08 1992-10-08

Publications (1)

Publication Number Publication Date
ATE244581T1 true ATE244581T1 (de) 2003-07-15

Family

ID=25500729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93308029T ATE244581T1 (de) 1992-10-08 1993-10-08 Fibrindichtungsmittelzusammensetzungen und verfahren zu deren verwendung

Country Status (24)

Country Link
US (12) US5750657A (de)
EP (2) EP0592242B1 (de)
JP (1) JP3771284B2 (de)
KR (1) KR940008697A (de)
CN (1) CN1091315A (de)
AT (1) ATE244581T1 (de)
AU (1) AU676201B2 (de)
BR (1) BR9304185A (de)
CA (3) CA2510981C (de)
CZ (1) CZ211793A3 (de)
DE (1) DE69333080T2 (de)
DK (1) DK0592242T3 (de)
ES (2) ES2065294B1 (de)
FI (1) FI110616B (de)
HU (1) HU218898B (de)
IL (1) IL107211A (de)
MX (1) MX9306272A (de)
NO (1) NO314412B1 (de)
NZ (3) NZ248897A (de)
PL (3) PL175443B1 (de)
PT (1) PT592242E (de)
RU (1) RU2143924C1 (de)
SG (1) SG49640A1 (de)
SK (1) SK109393A3 (de)

Families Citing this family (258)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7196054B1 (en) * 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US6241747B1 (en) 1993-05-03 2001-06-05 Quill Medical, Inc. Barbed Bodily tissue connector
US8795332B2 (en) 2002-09-30 2014-08-05 Ethicon, Inc. Barbed sutures
ZA948564B (en) * 1993-11-19 1995-07-26 Bristol Myers Squibb Co Liquid separation apparatus and method
EP0759762A4 (de) * 1994-05-02 1999-09-01 Squibb & Sons Inc Rekombinante fibrinketten, fibrin und fibrinhomologe
US6946079B1 (en) * 1994-12-02 2005-09-20 Bristol-Myers Squibb Company Centrifugal filtration method for separating fibrin monomer from blood
WO1996016713A1 (en) * 1994-12-02 1996-06-06 E.R. Squibb And Sons, Inc. Centrifuge reagent delivery system
PL320511A1 (en) * 1994-12-02 1997-10-13 Bristol Myers Squibb Co Method of and apparatus for isolating fibrin i from blood plasma
US5733446A (en) * 1994-12-02 1998-03-31 Bristol-Myers Squibb Company Centrifuge with annular filter
US5605541A (en) 1994-12-07 1997-02-25 E. R. Squibb And Sons, Inc. Fibrin sealant applicatoor
US5585007A (en) 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US6074663A (en) * 1995-01-16 2000-06-13 Baxter International Inc. Method of using cross-linked fibrin material
US5733545A (en) * 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
US5691152A (en) * 1995-11-09 1997-11-25 E. R. Squibb & Sons, Inc. Stable avidin composition
US6551794B1 (en) * 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
ES2227624T3 (es) 1995-12-07 2005-04-01 Bristol-Myers Squibb Company Dispositivo para aplicar una mezcla de dos componentes liquidos.
DE29723807U1 (de) * 1996-04-30 1999-11-04 Medtronic, Inc., Minneapolis, Minn. Autologe Fibrin-Blutstillungsmittel
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
AR013829A1 (es) 1996-07-12 2001-01-31 Baxter Int Un dispositivo medico para suministrar cantidades volumetricas de un primer y un segundo fluido, bioquimicamente reactivos, y metodo para suministrarfibrina a una superficie con dicho dispositivo
DE19634313A1 (de) * 1996-08-24 1998-02-26 Behringwerke Ag Methode zur Stabilisierung von Plättchen
US5844087A (en) * 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
CA2271738C (en) 1996-11-15 2008-06-03 Bristol-Myers Squibb Company Devices and methods for applying a mixture of two or more liquid components to form a biomaterial
US6613020B1 (en) 1996-12-06 2003-09-02 Bristol-Myers Squibb Company Method of applying a mixture of two liquid components as well as a device for carrying out the method
FR2757770B1 (fr) * 1996-12-30 1999-02-26 Inoteb Procede de preparation d'une colle biologique capable de coaguler par simple addition d'ions calcium
DE69836621T2 (de) 1997-01-08 2007-10-11 Bristol-Myers Squibb Co. Vorrichtung und verfahren zur herstellung von aus blut oder plasma bestehenden lösungen bekannter konzentration
US5849178A (en) * 1997-01-08 1998-12-15 Bristol-Myers Squibb Company Apparatus for separating a blood component from blood plasma
US6132598A (en) * 1997-01-08 2000-10-17 Bristol-Myers Squibb Company Centrifuge apparatus with temperature control means
NZ337922A (en) 1997-03-27 2001-09-28 Bristol Myers Squibb Co Laparoscopic sealant applicator having shaft end able to be articulated from handle
DE69842102D1 (de) 1997-04-14 2011-03-03 Baxter Int Austragevorrichtung für flüssigkeiten welches abgemessene mengen unter anwendung eines kontrollierten soges abgibt
US6331172B1 (en) 1997-04-14 2001-12-18 Baxter International Inc. Applicator for dispensing measured quantities with use of controlled suction
US5971956A (en) * 1997-04-15 1999-10-26 Biosurgical Corporation Medical suctioning apparatus and methods of use
US5931855A (en) 1997-05-21 1999-08-03 Frank Hoffman Surgical methods using one-way suture
GB9711927D0 (en) * 1997-06-09 1997-08-06 Bristol Myers Squibb Co Compositions useful as fibrin sealants
US7745106B2 (en) 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US6979307B2 (en) 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
IT1292410B1 (it) * 1997-06-24 1999-02-08 Roberto Beretta Contenitore di pronto impiego per ottenere colla di fibrina autologa
US6162241A (en) * 1997-08-06 2000-12-19 Focal, Inc. Hemostatic tissue sealants
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
CA2312476A1 (en) * 1997-12-09 1999-06-17 Bristol-Myers Squibb Company Fibrinogen-converting enzyme hybrids
US6492494B1 (en) 1997-12-09 2002-12-10 Bristol-Myers Squibb Company Method of making a fibrin sealant comprising alpha-2-antiplasmin
US6159232A (en) 1997-12-16 2000-12-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6478808B2 (en) * 1997-12-17 2002-11-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
EP1076517A4 (de) * 1998-05-06 2003-01-15 Bristol Myers Squibb Co Gerichteter endoskopischer materialtransport
US20020022588A1 (en) * 1998-06-23 2002-02-21 James Wilkie Methods and compositions for sealing tissue leaks
US6083383A (en) * 1998-06-25 2000-07-04 Huang; Xun Yang Apparatus for production of fibrin ogen or fibrin glue
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
JP2000070241A (ja) * 1998-08-31 2000-03-07 Nissho Corp 急速凝固用真空採血管
BE1012536A3 (fr) 1998-11-04 2000-12-05 Baxter Int Element muni d'une couche de fibrine sa preparation et son utilisation.
EP1731175B1 (de) 1998-11-12 2009-09-30 International Manufacturing Group, Inc. Hämostatische vernetzte Dextranperlen verwendbar zur schnellen Blutgerinnung und Hämostase
AU773128B2 (en) * 1998-11-18 2004-05-20 Csl Behring Gmbh Stabilised protein preparations for a tissue adhesive
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
DE19853033A1 (de) * 1998-11-18 2000-05-25 Centeon Pharma Gmbh Stabilisierte Proteinzubereitung für einen Gewebekleber
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
US6479052B1 (en) * 1998-12-02 2002-11-12 Bristol-Myers Squibb Company Spray delivery of cells
DE19858463A1 (de) * 1998-12-18 2000-06-21 Centeon Pharma Gmbh Verwendung eines Fibrinklebers zur Regeneration des Lebergewebes
US6310036B1 (en) 1999-01-09 2001-10-30 Last Chance Tissue Adhesives Corporation High strength, Bio-compatible tissue adhesive and methods for treating vigorously bleeding surfaces
US7015198B1 (en) 1999-05-11 2006-03-21 Orentreich Foundation For The Advancement Of Science, Inc. Materials for soft tissue augmentation and methods of making and using same
US6921412B1 (en) 1999-05-18 2005-07-26 Cryolife, Inc. Self-supporting, shaped, three-dimensional biopolymeric materials and methods
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
EP1185278A4 (de) * 1999-06-01 2002-09-18 Bristol Myers Squibb Co Fibrinpolymerstruktur
NZ515585A (en) * 1999-06-01 2004-06-25 Bristol Myers Squibb Co Prevention of post surgical adhesions using a fibrin monomer sealant
AU771328B2 (en) * 1999-06-01 2004-03-18 Vivolution A/S Fibrin sealants providing less inflammatory response and methods using same
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
WO2000077227A1 (en) * 1999-06-16 2000-12-21 Bristol-Myers Squibb Company Fibrin sealant as a transfection/transformation vehicle for gene therapy
US7654998B1 (en) * 1999-08-23 2010-02-02 Aeris Therapeutics, Inc. Tissue volume reduction
US6610043B1 (en) * 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
CA2316554C (en) 1999-08-25 2007-10-23 Bristol-Myers Squibb Company Applicator and electro-mechanical applicator drive system
US6463335B1 (en) 1999-10-04 2002-10-08 Medtronic, Inc. Temporary medical electrical lead having electrode mounting pad with biodegradable adhesive
WO2001032289A1 (en) * 1999-10-29 2001-05-10 Bristol-Myers Squibb Company Methods for preparing blood or plasma component solutions with improved concentrations
JP2003520830A (ja) 2000-01-25 2003-07-08 エドワーズ ライフサイエンシーズ コーポレイション 再狭窄および吻合内膜過形成処置のための送達系
US6187347B1 (en) 2000-02-09 2001-02-13 Ecosafe, Llc. Composition for arresting the flow of blood and method
JP3576063B2 (ja) * 2000-02-22 2004-10-13 株式会社ホギメディカル 凝固蛋白質を含む可溶性創傷治癒止血セルロース繊維とその製造方法
EP1155706A1 (de) * 2000-05-19 2001-11-21 Xun Yang Huang Apparat zur Herstellung von Fibrinkleber und seine medizinische Anwendung
AU7362301A (en) 2000-06-22 2002-01-02 Sam L Austin Bioadhesive compositions and methods of preparation and use
US6921532B1 (en) * 2000-06-22 2005-07-26 Spinal Restoration, Inc. Biological Bioadhesive composition and methods of preparation and use
JP2004508140A (ja) * 2000-09-11 2004-03-18 クロージャー　メディカル　コーポレイション 気管支閉塞法および装置
AU2001297782B2 (en) * 2000-11-07 2006-03-02 Cryolife, Inc. Expandable foam-like biomaterials and methods
US6942880B1 (en) * 2001-04-09 2005-09-13 Medtronic, Inc. Autologous platelet gel having beneficial geometric shapes and methods of making the same
US7795218B2 (en) 2001-04-12 2010-09-14 Bioaxone Therapeutique Inc. ADP-ribosyl transferase fusion variant proteins
CA2445239C (en) * 2001-04-25 2012-08-21 Eidgenossische Technische Hochschule Zurich Drug delivery matrices to enhance wound healing
US7056331B2 (en) 2001-06-29 2006-06-06 Quill Medical, Inc. Suture method
US6994722B2 (en) 2001-07-03 2006-02-07 Scimed Life Systems, Inc. Implant having improved fixation to a body lumen and method for implanting the same
US6848152B2 (en) 2001-08-31 2005-02-01 Quill Medical, Inc. Method of forming barbs on a suture and apparatus for performing same
US6692515B2 (en) * 2001-11-07 2004-02-17 Frank H. Boehm, Jr. Surgical kit for repairing leaks in fluid carrying vessels and organs and method thereof
AU2002361902A1 (en) * 2001-12-31 2003-07-24 Ares Medical, Inc. Hemostatic compositions and methods for controlling bleeding
DE10204405A1 (de) * 2002-02-04 2003-08-21 Surface Care Gmbh Plasmagel
AU2003225543A1 (en) * 2002-02-04 2003-09-02 Damage Control Surgical Technologies, Inc. Method and apparatus for improved hemostasis and damage control operations
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
AU2003249642A1 (en) 2002-05-24 2003-12-12 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
RU2219922C1 (ru) * 2002-06-28 2003-12-27 Общество с ограниченной ответственностью "Технобиофарм" Гемостатическое средство
US6773450B2 (en) 2002-08-09 2004-08-10 Quill Medical, Inc. Suture anchor and method
JP4777650B2 (ja) 2002-09-10 2011-09-21 アメリカン ナショナル レッド クロス 止血用包帯
US20040088003A1 (en) 2002-09-30 2004-05-06 Leung Jeffrey C. Barbed suture in combination with surgical needle
US8100940B2 (en) 2002-09-30 2012-01-24 Quill Medical, Inc. Barb configurations for barbed sutures
US7135027B2 (en) 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
JP3640655B2 (ja) * 2002-10-23 2005-04-20 一知 井上 血管新生誘導剤
US20050004599A1 (en) * 2003-06-30 2005-01-06 Mcnally-Heintzelman Karen M. Non-light activated adhesive composite, system, and methods of use thereof
US7943810B2 (en) 2003-02-04 2011-05-17 Buckman Robert F Method and apparatus for hemostasis
JP4585743B2 (ja) * 2003-02-13 2010-11-24 独立行政法人物質・材料研究機構 生体内分解吸収性粘着性医用材料
JP5346148B2 (ja) * 2003-03-28 2013-11-20 エー・デー・ガイストリヒ・ゾーネ・アクチェンゲゼルシャフト・フュール・ヒェーミシェ・インダストリー 抗新生物性組成物および治療方法
US20040224006A1 (en) * 2003-04-21 2004-11-11 Samn Raffaniello Ancrod irradiated, impregnated or coated sutures and other first aid or wound management bandaging materials for minimizing scarring and/or preventing excessive scar formation
US7624487B2 (en) 2003-05-13 2009-12-01 Quill Medical, Inc. Apparatus and method for forming barbs on a suture
US20070073338A1 (en) * 2003-09-04 2007-03-29 Roy Raghunandan Supercutaneous method and device for promoting hemostasis in cannulated patient
EP1673134A4 (de) 2003-09-12 2007-03-21 Marinepolymer Tech Inc Erhalt des gefässzugangs bei hämodialyse-patienten
US20050075713A1 (en) 2003-10-06 2005-04-07 Brian Biancucci Minimally invasive valve replacement system
WO2005046528A1 (en) 2003-10-06 2005-05-26 3F Therapeutics, Inc. Minimally invasive valve replacement system
EP2335650B1 (de) 2003-12-11 2012-10-03 Isto Technologies Inc. Teilchenförmiges Knorpelsystem
RU2242987C1 (ru) * 2003-12-15 2004-12-27 Киселев Сергей Александрович Гемостатическое средство
EP2664283B1 (de) 2004-05-14 2017-06-28 Ethicon, LLC Nähvorrichtungen
KR20070026578A (ko) * 2004-05-21 2007-03-08 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 조직 봉합제
WO2005122870A2 (en) 2004-06-14 2005-12-29 Pneumrx, Inc. Lung access device
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
WO2006009688A2 (en) 2004-06-16 2006-01-26 Pneumrx, Inc. Intra-bronchial lung volume reduction system
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
US20050281799A1 (en) 2004-06-16 2005-12-22 Glen Gong Targeting damaged lung tissue using compositions
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
WO2006001502A1 (ja) * 2004-06-24 2006-01-05 Tobishi Pharmaceutical Co., Ltd. バトロキソビンを含有する悪性腫瘍局所浸潤抑制剤
RU2358754C2 (ru) * 2004-06-24 2009-06-20 Тобиси Фармасьютикал Ко., Лтд. Препарат, ингибирующий развитие злокачественных опухолей, содержащий дез-а-фибрин
CA2570261C (en) * 2004-07-08 2014-06-10 Pneumrx, Inc. Pleural effusion treatment device, method and material
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US7597687B2 (en) * 2004-10-29 2009-10-06 Spinal Restoration, Inc. Injection of fibrin sealant including an anesthetic in spinal applications
US8124075B2 (en) * 2004-07-16 2012-02-28 Spinal Restoration, Inc. Enhanced biological autologous tissue adhesive composition and methods of preparation and use
US8206448B2 (en) 2004-10-29 2012-06-26 Spinal Restoration, Inc. Injection of fibrin sealant using reconstituted components in spinal applications
US8403923B2 (en) * 2004-10-29 2013-03-26 Spinal Restoration, Inc. Injection of fibrin sealant in the absence of corticosteroids in spinal applications
US8419722B2 (en) * 2004-10-29 2013-04-16 Spinal Restoration, Inc. Apparatus and method for injection of fibrin sealant in spinal applications
JP5014140B2 (ja) * 2004-10-18 2012-08-29 タイコ ヘルスケア グループ リミテッド パートナーシップ 接着性縫合構造体およびこれを用いる方法
EP1807514A1 (de) * 2004-10-22 2007-07-18 Benitec, Inc. Therapeutische rnai für behandlung von psoriasis
US20110213464A1 (en) * 2004-10-29 2011-09-01 Whitlock Steven I Injection of fibrin sealant in the absence of corticosteroids in spinal applications
JP4874259B2 (ja) 2004-11-23 2012-02-15 ヌームアールエックス・インコーポレーテッド 標的部位にアクセスするための操縦可能な装置
DE502006002488D1 (de) * 2005-01-14 2009-02-12 Eska Implants Gmbh & Co Verfahren zur herstellung einer osteoinduktiv-antiseptischen implantatbeschichtung
JP4961354B2 (ja) 2005-02-07 2012-06-27 ハヌマン リミテッド ライアビリティ カンパニー 多血小板血漿濃縮装置および方法
WO2006086201A2 (en) 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
US7766900B2 (en) 2005-02-21 2010-08-03 Biomet Manufacturing Corp. Method and apparatus for application of a fluid
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
RU2308287C2 (ru) * 2005-12-26 2007-10-20 Владимир Александрович Макаров Гемостатическое средство
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US9096839B2 (en) 2006-04-26 2015-08-04 Arteriocyte Medical Systems, Inc. Compositions and methods of preparation thereof
WO2007127390A2 (en) * 2006-04-28 2007-11-08 Biolife, L.L.C. Materials and methods for wound treatment
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8445009B2 (en) * 2006-08-04 2013-05-21 Stb, Ltd Processes for the production of solid dressings for treating wounded tissue
RU2468796C2 (ru) * 2006-09-07 2012-12-10 Эд. Гайстлих Зёне Аг Фюр Хемише Индустри Способ лечения рака костей
US20100297218A1 (en) * 2006-09-20 2010-11-25 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
US7968682B2 (en) * 2006-12-12 2011-06-28 Oregon Health & Science University Degradation-resistant fibrinogen sealants
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
WO2008081463A2 (en) * 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
GB2447012B (en) * 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2134297B1 (de) 2007-04-12 2017-03-08 Zimmer, Inc. Vorrichtung zur gewebereparatur
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US20080255612A1 (en) 2007-04-13 2008-10-16 Angiotech Pharmaceuticals, Inc. Self-retaining systems for surgical procedures
US20090075891A1 (en) * 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
EP2526975B1 (de) 2007-09-27 2014-06-04 Ethicon, LLC Selbsthaltende nähte mit gewebehaltern mit verbesserter festigkeit
CA2709328C (en) 2007-12-19 2017-01-03 Angiotech Pharmaceuticals, Inc. Self-retaining sutures with heat-contact mediated retainers
US8916077B1 (en) 2007-12-19 2014-12-23 Ethicon, Inc. Self-retaining sutures with retainers formed from molten material
US8118834B1 (en) 2007-12-20 2012-02-21 Angiotech Pharmaceuticals, Inc. Composite self-retaining sutures and method
EP2227263A2 (de) * 2007-12-28 2010-09-15 Kuros Biosurgery AG In fibrinschaum integrierte pdgf-fusionsproteine
EP2242430B1 (de) 2008-01-30 2016-08-17 Ethicon, LLC Vorrichtung und verfahren zur bildung von selbstfixierenden nähten
US8615856B1 (en) 2008-01-30 2013-12-31 Ethicon, Inc. Apparatus and method for forming self-retaining sutures
WO2009105663A2 (en) 2008-02-21 2009-08-27 Angiotech Pharmaceuticals, Inc. Method and apparatus for elevating retainers on self-retaining sutures
US8216273B1 (en) 2008-02-25 2012-07-10 Ethicon, Inc. Self-retainers with supporting structures on a suture
US8641732B1 (en) 2008-02-26 2014-02-04 Ethicon, Inc. Self-retaining suture with variable dimension filament and method
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8518272B2 (en) 2008-04-04 2013-08-27 Biomet Biologics, Llc Sterile blood separating system
US20090259263A1 (en) 2008-04-11 2009-10-15 Biomet Microfixation, Inc. Apparatus and methods of fixating bone
BRPI0911132B8 (pt) 2008-04-15 2021-06-22 Angiotech Pharm Inc sutura para ser usada em um procedimento aplicado ao tecido
US8961560B2 (en) 2008-05-16 2015-02-24 Ethicon, Inc. Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
WO2009152374A2 (en) 2008-06-12 2009-12-17 Medtronic Xomed, Inc. Method for treating chronic wounds
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
EP2346324A4 (de) 2008-10-06 2012-10-10 Microbial Defense Systems Llc Antimikrobielle zusammensetzung sowie verfahren zu ihrer herstellung und verwendung
EP3420923A1 (de) 2008-11-03 2019-01-02 Ethicon, LLC Länge einer selbsthaltenden naht und vorrichtung zur verwendung davon
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8110208B1 (en) 2009-03-30 2012-02-07 Biolife, L.L.C. Hemostatic compositions for arresting blood flow from an open wound or surgical site
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US20100256671A1 (en) * 2009-04-07 2010-10-07 Biomedica Management Corporation Tissue sealant for use in noncompressible hemorrhage
WO2010129258A2 (en) 2009-04-27 2010-11-11 Mallinckrodt Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
JP5809621B2 (ja) 2009-05-18 2015-11-11 ヌームアールエックス・インコーポレーテッド 患者の肺を治療するインプラント
US8367802B2 (en) * 2009-06-18 2013-02-05 Biomedica Management Corporation Method to produce fibrin monomer in acid media for use as tissue sealant
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
WO2011040888A1 (en) * 2009-10-01 2011-04-07 Singapore Health Services Pte Ltd A biodegradable composition or combination and uses thereof
US20110171285A1 (en) * 2009-10-28 2011-07-14 The Texas A&M University System Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
BR112012028331B1 (pt) 2010-05-04 2020-04-28 Ethicon Endo Surgery Llc sutura de autorretenção
CA2801271C (en) 2010-06-11 2018-10-30 Ethicon, Llc Suture delivery tools for endoscopic and robot-assisted surgery and methods
US10231721B2 (en) 2010-06-24 2019-03-19 St. Croix Surgical Systems, Llc Failsafe percutaneous wound barrier
US11007296B2 (en) 2010-11-03 2021-05-18 Ethicon, Inc. Drug-eluting self-retaining sutures and methods relating thereto
EP3138506B1 (de) 2010-11-09 2020-08-26 Ethicon, LLC Selbsthaltende notfallnähte
RU2659454C2 (ru) 2011-03-23 2018-07-02 ЭТИКОН ЭлЭлСи Самоудерживающиеся нити с регулируемой петлей
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
EP3456200B1 (de) 2011-05-10 2023-05-03 Next Science IP Holdings Pty Ltd Artikel mit einem antimikrobiellen feststoff und dessen verwendung
US20130172931A1 (en) 2011-06-06 2013-07-04 Jeffrey M. Gross Methods and devices for soft palate tissue elevation procedures
DE102011122227A1 (de) 2011-12-23 2013-06-27 Medizinische Hochschule Hannover Verfahren und Vorrichtung zur Herstellung eines bioartifiziellen Gewebekonstrukts
US20130202675A1 (en) * 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
WO2014052496A1 (en) 2012-09-25 2014-04-03 Stem Cell Partners Llc Method and apparatus for preparing single donor thrombin serum
US10016527B2 (en) 2012-10-23 2018-07-10 Orthovita, Inc. Materials and methods for repair of cartilage defects
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
US8906856B2 (en) * 2012-12-31 2014-12-09 Biomedica Mangement Corporation Single component fibrin hemostat
CN105007841A (zh) * 2012-12-31 2015-10-28 乔治·D.·福卢什 用于大量出血的冻干纤维蛋白封闭剂
WO2014121000A1 (en) * 2013-02-01 2014-08-07 Xcede Technologies, Inc. Minimally invasive surgery, including vascular closure, and associated sealants
RU2678878C2 (ru) 2013-02-12 2019-02-05 Репликэл Лайф Сайенсиз Инк. Композиции и способы для лечения и восстановления сухожилий
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
RU2522879C1 (ru) * 2013-04-23 2014-07-20 ОАО "Научно-исследовательский институт текстильных материалов" (ОАО "НИИТМ") Биодеградируемое гемостатическое лекарственное средство для остановки капиллярных и паренхиматозных кровотечений
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
IL230151A0 (en) * 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
TW201538730A (zh) 2014-02-12 2015-10-16 Replicel Life Sciences Inc 用於治療骨骼、關節及軟骨之組合物及方法
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
BR102014011436A8 (pt) * 2014-05-12 2018-01-09 Univ Estadual Paulista Julio De Mesquita Filho selante de fibrina para uso tópico, método de formação do mesmo e seu uso
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
WO2017027378A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US10501715B1 (en) 2015-09-11 2019-12-10 Mark H. Widick System for the formation of fibrin foam
RU2628809C1 (ru) * 2016-06-30 2017-08-22 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Гемостатическая губка и способ ее получения
FR3055805B1 (fr) 2016-09-09 2020-05-15 Assistance Publique - Hopitaux De Paris (Ap-Hp) Biomateriau a usage therapeutique
CN108220233B (zh) * 2016-12-21 2021-07-09 上海透景诊断科技有限公司 细胞分离器具表面处理方法、相关器具、外周血稀有细胞或循环肿瘤细胞快速高效分离方法
CN107589246B (zh) * 2017-03-07 2019-10-01 上海原科实业发展有限公司 一种纤维蛋白激活剂、其制备方法，包括该激活剂的试剂盒及采用该试剂盒的检测方法
RU179063U1 (ru) * 2017-07-03 2018-04-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации Салфетка с фибрином
WO2019074886A1 (en) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc LYOPHILIZATION CONTAINER AND METHOD OF USE
US11154637B2 (en) 2018-11-07 2021-10-26 Industrial Technology Research Institute Biodegradable sealant and use of a biodegradable sealant in manufacture of an agent for biological tissue adhesion or repair
CN109679946B (zh) * 2019-01-04 2020-11-13 宁波艾捷康宁生物科技有限公司 一种血液病毒rna保护剂及采血管
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
RU2749983C1 (ru) * 2020-11-09 2021-06-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ герметизации панкреато-кишечного анастомоза с применением фибринового композита
EP4274625A1 (de) * 2021-01-07 2023-11-15 Baxter International Inc. Thrombinfreie hämostatische materialien, verfahren zur herstellung und verwendungen davon
JP2025519280A (ja) 2022-05-17 2025-06-25 ユリウス－マキシミリアンズ－ユニヴァーシタエト ビュルツブルク 手術創ケア用のフィブリンシーラントのための新規組換えフィブリノーゲンバリアント

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533004A (en) * 1943-10-27 1950-12-05 John D Ferry Fibrin clots and methods for preparing the same
CH586233A5 (de) * 1971-01-18 1977-03-31 Pentapharm Ag
GB1417003A (en) * 1972-06-22 1975-12-10 Radiochemical Centre Ltd Stabilisation of fibrinogen
US3915640A (en) * 1974-08-06 1975-10-28 Warner Lambert Co Method and composition for detecting fibrin monomers and fibrin degradation products
SU663404A1 (ru) * 1976-12-30 1979-05-25 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им. М.В.Ломоносова Способ получени фибрин-мономера
US4442650A (en) * 1977-12-15 1984-04-17 Sivachenko Eugene W Girder construction
US4167823A (en) * 1978-06-21 1979-09-18 Kumming Deborah G Coagulation puzzle for teaching coagulation theory
JPS5598196A (en) * 1979-01-16 1980-07-25 Meito Sangyo Kk Fractionation of fibrinogen or its constituents and their use
SE417342B (sv) * 1979-02-05 1981-03-09 Nya Asfalt Ab Forfarande och anordning for grundleggning av for tillverkade anleggningar i land
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3017707A1 (de) * 1980-05-08 1981-11-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagens zum nachweis von fibrinmonomer
US4488198A (en) * 1981-01-15 1984-12-11 Sundstrand Corporation Protective circuit for clutchless parallel generating system
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
US4480029A (en) * 1981-04-27 1984-10-30 Baxter Travenol Laboratories, Inc. Biological indicators and their use
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
ATE13810T1 (de) * 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
EP0068149A3 (de) * 1981-06-25 1983-07-20 Serapharm GmbH & Co. KG Fibrinogen-haltiges Trockenpräparat, dessen Herstellung und Verwendung
US4438198A (en) * 1981-09-30 1984-03-20 Trimedyne, Inc. Biochemically active matrix for use in a bio-artificial organ
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
US4927916A (en) * 1984-04-23 1990-05-22 The General Hospital Corporation Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides
DE3430906A1 (de) * 1984-08-22 1986-02-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung von fibrinmonomer in plasma
US4928603A (en) * 1984-09-07 1990-05-29 The Trustees Of Columbia University In The City Of New York Method of preparing a cryoprecipitated suspension and use thereof
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US5223420A (en) * 1985-03-01 1993-06-29 Institut National De La Sante Et De La Recherche Medicale Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials and artificial supports
SE447579B (sv) * 1985-04-01 1986-11-24 Biopool Ab Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DD261844A1 (de) * 1986-07-09 1988-11-09 Adw Ddr Verfahren zur praezipitation von fibrinmonomeren
US4714457A (en) * 1986-09-15 1987-12-22 Robert Alterbaum Method and apparatus for use in preparation of fibrinogen from a patient's blood
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US4915847A (en) * 1987-08-04 1990-04-10 Baxter International Inc. Cryoglobulin separation
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
US4709037A (en) * 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
US5175087A (en) * 1987-07-06 1992-12-29 Biopool International, Inc. Method of performing tissue plasminogen activator assay
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
DE3819923A1 (de) * 1988-06-11 1989-12-21 Behringwerke Ag Fibrin(ogen)derivate, verfahren zu ihrer herstellung und ihre verwendung
JPH03501777A (ja) * 1988-10-17 1991-04-18 モレキユラー　デヴアイシズ　コーポレイシヨン ハプテン誘導捕獲膜及び該膜を使用する診断アツセイ法
JPH02129234A (ja) * 1988-11-09 1990-05-17 Kanebo Ltd 難燃性フェノール系樹脂プリプレグ
JPH02129224A (ja) * 1988-11-10 1990-05-17 Terumo Corp フィブリンの製造法
DE3900493A1 (de) * 1989-01-10 1990-07-12 Thomae Gmbh Dr K Verfahren zur bestimmung der fibrinolytischen gesamtaktivitaet im plasma
US5026785A (en) * 1989-05-12 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Avidin and streptavidin modified water-soluble polymers such as polyacrylamide, and the use thereof in the construction of soluble multivalent macromolecular conjugates
CA1335361C (en) * 1989-05-24 1995-04-25 Andrei Z. Budzynski Thrombus-targeted complexes of plasminogen activator and fibrin fragments
US5226877A (en) * 1989-06-23 1993-07-13 Epstein Gordon H Method and apparatus for preparing fibrinogen adhesive from whole blood
FR2649982B1 (fr) * 1989-07-20 1991-09-27 Inst Nat Sante Rech Med Membrane biologique artificielle
ES2062394T3 (es) * 1989-09-29 1994-12-16 Rohm & Haas Medio que contiene un ligando para la separacion cromatografica, procedimiento para la preparacion del medio y uso del medio para aislar moleculas naturales o sinteticas de una mezcla liquida.
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5030215A (en) * 1990-01-03 1991-07-09 Cryolife, Inc. Preparation of fibrinogen/factor XIII precipitate
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5185001A (en) * 1990-01-18 1993-02-09 The Research Foundation Of State University Of New York Method of preparing autologous plasma fibrin and application apparatus therefor
US5180828A (en) * 1990-02-09 1993-01-19 Molecular Devices Corporation Chromophoric reagents for incorporation of biotin or other haptens into macromolecules
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
AU644205B2 (en) * 1990-08-23 1993-12-02 New York Blood Center, Inc., The Assays using a soluble fibrin-like monomer
AU8702491A (en) * 1990-11-08 1992-05-14 Matrix Pharmaceutical, Inc. Fibrin/collagen membrane material for biomedical use
EP0485904B1 (de) * 1990-11-13 1997-08-20 Kyowa Hakko Kogyo Co., Ltd. Mitomycinderivate
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
CH681693A5 (de) * 1991-02-28 1993-05-14 Pentapharm Ag
EP0534178B1 (de) * 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Verbesserter Gewebekleber, zubereitet aus Kryopräzipitat
US5527692A (en) * 1991-12-31 1996-06-18 Zymogenetics, Inc. Methods for producing thrombin
US5272074A (en) * 1992-04-23 1993-12-21 Mcmaster University Fibrin coated polymer surfaces
US5443959A (en) * 1992-09-09 1995-08-22 Tokuyama Corporation Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5292416A (en) * 1992-11-13 1994-03-08 Indiana University Foundation Pulsed-field separation of polysaccharides in capillaries
US5520885A (en) * 1993-01-19 1996-05-28 Thermogenesis Corporation Fibrinogen processing apparatus, method and container
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
AU696691C (en) * 1993-03-12 2003-09-18 American National Red Cross, The Supplemented and unsupplemented tissue sealants, methods of their production and use
US5464471A (en) * 1994-11-10 1995-11-07 Whalen Biomedical Inc. Fibrin monomer based tissue adhesive
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
EP0841108A1 (de) * 1996-11-06 1998-05-13 Norsk Hydro ASA Verfahren zur Verbindung von Metallelementen

Also Published As

Publication number Publication date
NZ280264A (en) 1997-08-22
PL176202B1 (pl) 1999-04-30
NO314412B1 (no) 2003-03-17
ES2065294A1 (es) 1995-02-01
US6077507A (en) 2000-06-20
PT592242E (pt) 2003-11-28
US5962026A (en) 1999-10-05
EP1266666A3 (de) 2003-01-22
IL107211A (en) 1997-09-30
HU218898B (hu) 2000-12-28
BR9304185A (pt) 1994-05-03
US5750657A (en) 1998-05-12
NO933624D0 (no) 1993-10-08
ES2065294B1 (es) 1995-11-01
CN1091315A (zh) 1994-08-31
EP0592242B1 (de) 2003-07-09
DE69333080D1 (de) 2003-08-14
ES2202306T3 (es) 2004-04-01
US5763410A (en) 1998-06-09
CZ211793A3 (en) 1996-04-17
HUT66587A (en) 1994-12-28
NZ328064A (en) 2000-08-25
JP3771284B2 (ja) 2006-04-26
MX9306272A (es) 1994-07-29
US5804428A (en) 1998-09-08
US5763411A (en) 1998-06-09
CA2108104C (en) 2005-09-27
HU9302839D0 (en) 1994-01-28
PL175443B1 (pl) 1998-12-31
KR940008697A (ko) 1994-05-16
CA2510981A1 (en) 1994-04-09
AU4887893A (en) 1994-04-21
US5962420A (en) 1999-10-05
JPH06199685A (ja) 1994-07-19
EP1266666A2 (de) 2002-12-18
NZ248897A (en) 1996-08-27
US6262236B1 (en) 2001-07-17
AU676201B2 (en) 1997-03-06
CA2510981C (en) 2007-02-13
DE69333080T2 (de) 2004-04-15
SG49640A1 (en) 1998-06-15
US5770194A (en) 1998-06-23
FI934440L (fi) 1994-04-09
EP0592242A1 (de) 1994-04-13
US5773418A (en) 1998-06-30
US6048966A (en) 2000-04-11
CA2108104A1 (en) 1994-04-09
RU2143924C1 (ru) 2000-01-10
CA2566574A1 (en) 1994-04-09
DK0592242T3 (da) 2003-10-27
IL107211A0 (en) 1994-01-25
PL173858B1 (pl) 1998-05-29
NO933624L (no) 1994-04-11
FI110616B (fi) 2003-02-28
FI934440A0 (fi) 1993-10-08
SK109393A3 (en) 1994-06-08
US5739288A (en) 1998-04-14

Similar Documents

Publication Publication Date Title
DE69333080D1 (de) Fibrindichtungsmittelzusammensetzungen und Verfahren zu deren Verwendung
RU93058414A (ru) Способы использования фибринового герметика, способ получения состава, составы, наборы
DE69316717D1 (de) Inhibitoren mit zweifacher Wirkung
FI952162A7 (fi) Polymeerikoostumus, joka sisältää polyhydroksialkanoaattia ja metalliy hdistettä
DE69420975D1 (de) Amido-siladiylverbrückte katalysatorkomponente, verfahren zur herstellung und verwendung
NO302076B1 (no) Strålings-sensitive blokk-kopolymerer, fremgangsmåte for fremstilling av slike, og materialer som inneholder slike kopolymerer
ATE143952T1 (de) Polyoxazolidine mit carbonat-gruppen, verfahren zu ihrer herstellung und ihre anwendung
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
WO2000006658A3 (en) Adhesives and sealants
DE59400813D1 (de) Cobalt-Cobaltoxidpulver, Verfahren zu seiner Herstellung sowie dessen Verwendung
PL336857A1 (en) Heterocyclic compounds, method of obtaining them and pharmaceutic composition containing such compounds
NO177461C (no) Trijodbenzenforbindelser og kontrastmidler inneholdende disse
FR2565595B1 (fr) Systeme de catalyseur et composition d'adhesif acrylique
DE69005333D1 (de) Polyoxazolidine, Verfahren zu ihrer Herstellung und ihre Verwendung.
FI903950A0 (fi) Ny komposition.
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
DK363685A (da) Katalysatorsammensaetning og anvendelse heraf til fremstilling af hydrogenholdige forbindelser
DE69620418D1 (de) Terpenzusammensetzungen und ihre verwendung zur entfernung von dichtungsmassen
DE3778057D1 (de) Stabile zusammensetzung von thiocyanogen und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0592242

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee